-
P338369-1gPropargyl-PEG4-amine.
-
P338369-250mgPropargyl-PEG4-amine.
-
P189135-100gPropynol ethoxylate.
-
P189135-25gPropynol ethoxylate.
-
P189135-500gPropynol ethoxylate.
-
P189135-5gPropynol ethoxylate.
-
P393057-100μgProstaglandin E2-PEG11-biotinamide is a functionalized derivative of PGE2 (sc-201225) - the most physiologically abundant eicosanoid, which is produced predominantly from arachidonic acid (sc-200770) by COX and PGES, and exists at some level in
-
P393057-50μgProstaglandin E2-PEG11-biotinamide is a functionalized derivative of PGE2 (sc-201225) - the most physiologically abundant eicosanoid, which is produced predominantly from arachidonic acid (sc-200770) by COX and PGES, and exists at some level in
-
P648776-1mgPROTAC BRD4 Degrader-10 (compound 8b) is a PROTAC connected by ligands for von Hippel-Lindau and BRD4. PROTAC BRD4 Degrader-10 can be conjugated with STEAP1 and CLL1 antibodies to degrade the BRD4 protein in PC3 prostate cancer cells, with a DC 50
-
P648776-5mgPROTAC BRD4 Degrader-10 (compound 8b) is a PROTAC connected by ligands for von Hippel-Lindau and BRD4. PROTAC BRD4 Degrader-10 can be conjugated with STEAP1 and CLL1 antibodies to degrade the BRD4 protein in PC3 prostate cancer cells, with a DC 50
-
P647304-1mgPROTAC BRD4 Degrader-12 (compound 9c) is a PROTAC connected by ligands for von Hippel-Lindau and BRD4. PROTAC BRD4 Degrader-12 can be conjugated with STEAP1 and CLL1 antibodies to degrade the BRD4 protein in PC3 prostate cancer cells, with a DC 50
-
P647304-5mgPROTAC BRD4 Degrader-12 (compound 9c) is a PROTAC connected by ligands for von Hippel-Lindau and BRD4. PROTAC BRD4 Degrader-12 can be conjugated with STEAP1 and CLL1 antibodies to degrade the BRD4 protein in PC3 prostate cancer cells, with a DC 50